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Abstract
Background: Direct manipulation of the genome is a widespread technique for genetic studies and synthetic
biology applications. The tyrosine and serine site-specific recombination systems of bacteriophages HK022 and
ΦC31 are widely used for stable directional exchange and relocation of DNA sequences, making them valuable
tools in these contexts. We have developed site-specific recombination tools that allow the direct selection of
recombination events by embedding the attB site from each system within the β-lactamase resistance coding
sequence (bla).
Results: The HK and ΦC31 tools were developed by placing the attB sites from each system into the signal
peptide cleavage site coding sequence of bla. All possible open reading frames (ORFs) were inserted and tested
for recombination efficiency and bla activity. Efficient recombination was observed for all tested ORFs (3 for HK,
6 for ΦC31) as shown through a cointegrate formation assay. The bla gene with the embedded attB site was
functional for eight of the nine constructs tested.
Conclusions: The HK/ΦC31 att-bla system offers a simple way to directly select recombination events, thus
enhancing the use of site-specific recombination systems for carrying out precise, large-scale DNA manipulation,
and adding useful tools to the genetics toolbox. We further show the power and flexibility of bla to be used as
a reporter for recombination.
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Background
The ability to precisely and directly manipulate DNA is
important for functional studies and the synthetic as-
sembly of large genetic constructs. Site-specific recom-
binase (SSR) systems are widely used as tools to
rearrange, insert, remove, and join DNA with virtually
no upper limit in size. For biotechnology purposes, this
can include the insertion of exogenous DNA into chro-
mosomes, the fusing of DNA molecules, or the con-
struction of synthetic gene networks [1]. The tyrosine
(Y-rec) and serine (S-rec) recombination families are
named for the catalytic residue of their respective inte-
grase (Int) protein. Important members of the Y-rec
family include the λ-like phage recombination systems,
which include λ and the closely related phage HK022
(hereafter referred to as HK). The ΦC31 recombinase
system is an important member of the S-rec family [2].
Both HK and ΦC31 systems comprise attB/attP attach-
ment sites that serve as points of recombination, and
the recombinases that catalyze recombination. In each
family, DNA exchange requires host-encoded proteins
for recombination that differ between systems. These
systems are attractive due to their directionality and sta-
bility, and both systems are functional in prokaryotic
and eukaryotic organisms [3–5].
Mechanistically, attB and attP integrative recombin-
ation forms attL and attR sites. The reverse attL x attR
excisive reaction also requires Int as well as a recombin-
ation directionality factor (RDF), named Xis in the HK
system and gp3 in the ΦC31 system [6], typically sup-
plied in trans from a helper plasmid, a non-replicating
DNA molecule, or as mRNA [7]. Structurally, HK and
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ΦC31 att sites differ in size, with the HK attB sites being
generally shorter than the HK attP sites, 21 base pairs
(bp) vs 234 bp [8, 9]; in addition, attP contains binding
sites for Int and Xis along with host-encoded proteins
Fis and IHF [8–11]. ΦC31 attB and attP sites are similar
in size (~50 bp) and do not require additional proteins
to carry out recombination [12].
The use of SSRs generally involves selecting the
recombination event through the use of a marker gene
within the inserted sequence whose presence or absence
would indicate successful integration [1]. Genes can be
activated following recombination through either re-
moval of blocking DNA sequences or by bringing to-
gether physically separated congruous sequences, with
the recombination site embedded within the gene or be-
tween the promoter and coding sequence. This approach
has long been used with the popular CRE/loxP [13] and
Flp/FRT [14] systems. The β-lactamase (bla) gene is an
attractive marker, as it is a useful reporter gene for both
pro- and eukaryotic applications [15]. Protein chimeras
of β-lactamase demonstrate tolerance to exogenous pep-
tide insertions [16], even for domains of unknown func-
tion [17]. A split gene reassembly approach using bla
has also been developed to discover directed evolution-
modified SSR enzymes capable of recombining designer
sequences [18]. The bla signal peptide is an attractive re-
gion for peptide insertion [19], as insertions between the
signal peptide sequence and the rest of the coding gene
have minimal interference with protein function [20]. As
we wished to expand the available molecular toolbox, we
created a set of recombination reporters consisting of
the attB of HK and ΦC31 inserted in frame with bla,
allowing expression of the gene and enabling the direct
selection of recombination events. The selective agent is
not expressed when the att sites are in attL and attR
form, as the reporter gene fragments are physically
separated (Fig. 1a).
This approach has been used to explore the physical
structure of the E. coli genome [21, 22]. Genome engin-
eering of the two Vibrio cholerae chromosomes used this
tool to understand the evolutionary and genetic implica-
tions of multi-chromosomal bacteria [23]. We have used
HK recombination in tandem with the λ-lacZ system
from [21] to exchange DNA between the two V. cholerae
chromosomes in a recombination-mediated cassette
exchange (RMCE), resulting in large-scale chromosomal
rearrangements [23]. Because the lacZ reporter allows
the observation of recombination events but not to se-
lect for them, we developed a reporter system for HK re-
combination based on antibiotic selection. We have used
an HK attB site placed in-frame within the β-lactamase
(bla) gene to carry out relocation of the S10-spec-α ribo-
somal locus in V. cholerae in order to study the conse-
quences of essential gene positioning as it relates to
dosage [24]. We further used HK-bla to carry out
large-scale genome inversions around the origin region
(ori) of V. cholerae chromosome one (Chr1) to shift the
timing of the initiation of chromosome two (Chr2) rep-
lication relative to Chr1 in order to study the mecha-
nisms involved in bacterial chromosome replication
timing [25].
Here, we describe the construction and validation of
HK-bla and a similar tool using the serine ΦC31 att
system (ΦC31-bla). We placed attB sites from each
system immediately downstream of the bla signal
peptide coding sequence, which directs transport of
β-lactamase to the periplasm and is removed in the
mature protein. β-lactamase is generally tolerant of
insertions into this region. When each system is
present as attL and attR sites, they are associated
with fragment sequences bla’ (the 5′ region upstream
of the cleavage site including the promoter and signal
sequence) and ‘bla (the 3′ region comprising the ma-
ture protein sequence), respectively (Fig. 1a). In
addition, the cognate att site partners show high re-
combination frequencies without the presence of bla-
resistant background from the fragmented bla gene.
These systems are extremely useful due to their abil-
ity to directly select for recombination through resist-
ance to β-lactam antibiotics. They also have the
potential to be used within synthetic biology frame-
works for constructing and precisely inserting large
genetic assemblies, making them useful additions to
the molecular biology toolbox for both synthetic and
molecular applications.
Results
In-frame insertion of attBHK sites within the ß-lactamase gene
The β-lactamase gene has a 23-amino acid (aa) signal
peptide sequence for protein transmembrane trans-
port that is cleaved during protein maturation [26].
We inserted the attB sequences in frame into the
junction between the encoded signal sequence and
the mature protein (Fig. 1a), as this region is tolerant
to sequence insertions [19]. To avoid interfering with
the β-lactamase coding sequence we took into ac-
count attB length and the amino acid sequence of
the translated att sequence, so as to avoid frameshift
or stop codon insertion.
Recombination frequency in attBHK sites decreases with size
The attBHK site comprises a 7 bp core, or overlap, (O)
region where strand exchange occurs, and flanking B
and B′ arm regions of 7 bp each that are recognized by
Int monomers to form a synaptic complex, although
sites shorter than this 21 bp have been shown to be
functional but with low efficiency [27]. To allow recom-
bination, the O region between attB and attP must
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perfectly overlap, and the arm regions must share simi-
larity. Flanking the core minimal region, there are hom-
ologous nucleotides that may play an additional role in
recombination efficiency [10, 28]. Insertion of attB into
bla extends the gene and could affect either transport
through the membrane or mature enzyme function. It is
therefore necessary to test different open reading frames
encoded by the attBHK sequence to avoid unwanted
interference with bla. The native attBHK sequence
encodes two open reading frames (ORFs) that do not
have stop codons. As we wished to increase the potential
sequences we could test within bla, we added a third
potential ORF by mutating one bp just outside of the B′
region (Fig. 1c; Fig. 2a) [8, 27]. We compared these
“mutant” attB sites to the “wild-type” sites to ensure
there was no loss of recombination frequency (Fig. 1d).
The 23, 33, and 51 bp “wild type” and “mutant” attBHK
sequences were tested by placing them on the condition-
ally replicating conjugative plasmid pSW23T containing
an oriTRP4 for plasmid conjugation and oriVR6Kγ for π
protein replication dependence (Fig. 1b); [29]. As these
plasmids do not replicate in bacterial strains not
expressing the π protein, conjugation into non-π
expressing DH5α leads to plasmid loss unless att recom-
bination occurs. The DH5α recipient strain houses
plasmid pHK11Δamp, which has the attPHK partner site,
and pHK-Int, which expresses the HK integrase under
control of the temperature-dependent CI857 promoter
[30]. Following conjugation, recombination frequency
was calculated by measuring the ratio of recovered
colonies (representing co-integrates) over the number of
recipient colonies [31]. Recombination frequencies were
Fig. 1 Schematic representation of attB-bla system and the conjugative assay used to test att sites. a In the selective tool, the bla gene is
fragmented such that the 5′ promoter and signal sequence are associated with an attL site, and the partner attR is associated with the 3′ region.
Each component is placed at separate loci, either on the genome or a plasmid, depending on the application. b Conjugation of the attB plasmid
into a recipient strain containing the attP and integrase plasmids to form the attR and attL partners with bla gene fragments. c Sequence of the
HK022 attB site. We tested attBHK sites of three different lengths to avoid potential interference with bla function and protein export, 51 bp
(violet), 33 bp (teal), and 23 bp (black). To increase the number of potential open reading frames, we introduced a T ➔ A nucleotide change into
the attB sequence, indicated in red. The BOB’ core region is demonstrated by black lines. Stars indicate bases in common with attPHK.
Recombination points flank the core O region. d Recombination results of attBHK sequences. These six sequences were tested using a plasmid
conjugation assay in a context independent of the bla gene [29]. This demonstrated that the introduced mutation did not interfere with
recombination efficiency and the length of the attB site had a negative correlation with recombination frequency. As we wished to use a shorter
sequence to avoid interfering with bla functionality following attB site insertion, we based our subsequent ORF constructions on the 23 bp mut
form, despite the fact that it recombines at a lower frequency than the 51 and 33 bp wt sequences
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similar between the different sites, with only a 10-fold
reduction in recombination observed for the 23 bp sites
compared to the larger attB sites (Fig. 1c). As we wished
to use a shorter sequence to avoid interfering with bla
functionality following attB site insertion, we based our
subsequent tests on the 23 bp attBHK mutant form.
Fig. 2 Sequences and recombination frequencies of HK and ΦC31 attB sites. The three ORFs for HK and the six ORFs for ΦC31 were inserted into bla
and tested using the conjugation assay as in Fig. 1a. The six open reading frames of the 23 bp attB HK site are shown. As in Fig. 1, black nucleotides
represent the 23 bp HK sequence, with the corresponding amino acids also in black. The red nucleotide shows the base changed from the original attB,
with the resulting amino acid changes also shown in red. Nucleotides and amino acids in teal represent sequences flanking the 23 bp site. Horizontal
arrows indicate the direction of transcription, and asterisks indicate a stop codon. For both a and b, the sequence of recombination exchange is
indicated by a horizontal red line. As described in the text, three open reading frames did not have a stop codon and were able to be tested for bla
insertion. The recombination frequencies of these open reading frames compared to the 23 bp HK attB site are shown in the bar graph. The open
reading frames are also shown in context of the bla sequence flanking the insertion site. Note that to keep the attB site in frame with bla, nucleotides
were added to either the 5′ or 3′ end of the site, which changed the expected amino acid residue for ORFs 1 and 3 compared to the original attB. The
background colors highlighting the sequence correspond to Fig. 1a. The recombination frequencies of the different ORFs were compared using 1-way
ANOVA followed by a Tukey-Kramer test. Each of the HK ORF recombination frequencies are significantly different (p < 0.05). b. None of the six ΦC31
ORFs encode a stop codon. ORFs 1 and 2 recombine at a higher rate than ORFs 3–6 (p < 0.001)
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Placing a single nucleotide mutation in the 23 bp
attBHK site enables the use of three ORFs that would
potentially allow bla function following their insertion
into the gene (Fig. 2a). These ORFs were inserted separ-
ately into bla downstream of the signal sequence and
cloned into pSW23T in a π + host. Following construc-
tion of these plasmids, we measured the ampicillin
minimum inhibitory concentration (MIC) of each to
test and measure bla function. All ORFs provided re-
sistance to ampicillin at an MIC >256 μg/ml (Table 1).
Recombination frequencies were then tested using the
conjugation assay as above. The three HK ORF con-
structions demonstrated a wide range of recombination
efficiencies, with the ORF 2 construct recombining at
the highest level, and the ORF 3 construct recombining
at the lowest (Fig. 2a). Thus, we used ORF 2 for the
final construction of this tool.
ΦC31 attB x attP recombination is functional in all six ORFs
We designed attBΦC31 sites for all six possible ORFs
maintaining at least the minimal sequence necessary for
recombination [32] and inserted them into bla. Ampicil-
lin resistance and recombination frequency were deter-
mined as with the HK system. Five of six ORFs were
found to provide MICs greater than 256 μg/ml, with the
ORF 5 construction being the only sequence to interfere
with β-lactamase function (MIC = 6 μg/ml - Table 1).
ΦC31 pSW23T-bla plasmids were conjugated into a
DH5α strain harboring plasmids pΦC31-Int and
pΦC31-attP. All six ORFs were able to recombine suc-
cessfully, with ORF constructions 1 and 2 recombining
at a higher rate, on the order of 10−2, than ORFs 3–6,
which recombined at an average rate of 10−3 (Fig. 2b).
We found this difference to be significant using a 1-way
ANOVA (p < 0.001) followed by a post-hoc Tukey-
Kramer test (p < 0.001). Additionally, all six ΦC31 ORF
constructions recombined at a higher rate than HK
ORFs 1–3 (Fig. 2).
Discussion
In this study, we describe the construction of two site-
specific recombination tools useful for DNA manipula-
tion applications. The utility of this attB-bla tool is
based on its incorporation of the widely used HK and
ΦC31 recombination systems. In the case of HK, the
removal of sequences flanking the BOB’ core region
reduced attB x attP recombination. This reduction could
be due to the removal of bases outside of the attB core
that have homology with the attP sequence, which may
act to stabilize the attB/attP complex. However, obtain-
ing the highest possible recombination frequency was
not critical for the design of this system, as our main
concern was β-lactamase function following insertion of
the att sites into the bla coding frame.
In directly comparing the two systems, the ΦC31 site
appears to recombine at a similar frequency to the 51 bp
HK sites and the 23 bp HK ORFs incorporated into bla
have a lower recombination frequency (Fig. 2). This de-
crease is likely due to the reduction of size of the attBHK
site, as the recombination frequencies for the smaller
HK site tested independently of bla insertion are not dif-
ferent from the frequencies obtained when they are em-
bedded in bla (Fig. 1). Reported differences between
recombination systems in the literature may result from
differences in protocols and practices. A recent review of
ΦC31 found a wide range of reported recombination fre-
quencies for this recombinase [33]. To our knowledge, the
only information comparing HK and ΦC31 recombination
frequencies reports HK recombining at a higher frequency
than ΦC31 [34]. However, this study used a clonetegration
technique where constructs were recombined into native
att sites on either the E. coli chromosome for attPHK or
Salmonella typhimurium for attPΦC31.
While testing bla expression with inserted ORFs, we
observed that ΦC31 ORF 5 interfered with bla expres-
sion, while ΦC31 recombination was not affected
(Table 1, Fig. 2b). The bla gene used for our system
originates from pBR322 and belongs to the TEM-1 class
of β-lactamases. The signal sequence is recognized by
the Sec export pathway that transports unfolded pro-
teins across the cytoplasmic membrane [26, 35]. DNA
secondary structures could be a source of transcription
interference, as ORF 5 forms a 30 bp hairpin (ΔG at
37 °C = −9.09 kcal/mol). However, hairpins are formed
in all 6 ORFs at similar ΔG, making it unlikely that this
factor alone prevents bla expression. At the translation
level, the overall charge of the first 5 amino acids fol-
lowing the signal sequence can influence cleavage and
cross-membrane transport, as they generally have an
overall negative charge [36]. For ORF 5, the overall
negative charge of this region is +2. Again, however,
this is unlikely to explain the loss of bla expression, as
only ORF 1 has an overall negative charge, at −1. The
Table 1 Minimum inhibitory concentration (MIC) of attBHK and
attBΦC31 ORFs inserted into β-lactamase
Ampicillin Resistance of bla-attB ORFs MIC (μg/ml)
HK022 ORF1 > 256
HK022 ORF2 > 256
HK022 ORF3 > 256
ΦC31 ORF1 > 256
ΦC31 ORF2 > 256
ΦC31 ORF3 > 256
ΦC31 ORF4 > 256
ΦC31 ORF5 6
ΦC31 ORF6 > 256
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amino acids in the 1 and 2 position after the cleavage site
can also influence protein function [37, 38]. For ORF 5, the
first two amino acids are glycine and serine. Analysis of
307 proteins from the SPdb database [39] found that in
Gram-negative bacteria, glycine occurs in the 1st position
in 6.19% of proteins, and serine appears in the 2nd position
in 5.54% of proteins. [40]. Additionally, two of the 307
Gram-negative proteins analyzed in this study begin with
glycine-serine. Thus it is unlikely that the first two residues
of the ORF 5 sequence alone interfere with protein trans-
port. More experimental and analytical work is needed to
determine the source of bla expression interference.
The high tolerance of bla to in-frame DNA sequence
insertion downstream of the bla promoter and leader
peptide sequence allows for further modifications of this
system through insertion of potentially large ORFs. This
approach has already been proposed as an “ORF-trap” to
capture DNA encoding protein fragments [41]. Indeed,
large ORFs in frame with bla may not greatly reduce β-
lactamase function, although export to the periplasm
can be inhibited [42]. Additionally, as attB and attP site
reactivity can be modified through mutations to their
respective core sequences, variable non-reacting “synthetic”
att sites can be designed for sequential introduction into
the bacterial chromosome [43].
Integration of exogenous DNA sequences into genomes
by SSRs generally involves the recombination of an attP
site on the inserted sequence with an endogenous
chromosomal attB or pseudo-attB site [1]. The use of
genome editing technologies allows the insertion of re-
combination sites that differ from native sites in location
and sequence. Native att sites may be located in undesir-
able regions of the genome, for example, in an active gene
locus, or a locus subject to silencing. Additionally, dosing
effects can be observed in bacterial species dependent on
a gene’s location in the chromosome [24]. Engineering att
site recognition by Int proteins allows the creation of
semi-synthetic partner sites [27, 43]. This would avoid re-
combination with other native att sites, and could allow
rapid construction of synthetic gene networks. The
addition of FRT sites flanking the bla-attB cassette would
further allow for removal of the resistance selection
marker gene. Similarly, gene-editing technologies could
allow the targeted insertion of att sites to serve as landing
pads for insertion. In this way, the bla’-attL sequence from
our system can be inserted into a genome, into which a
sequence containing the partner attR-‘bla can be inserted
through attL x attR recombination. This framework has
already been proposed for the construction and insertion
of metabolic networks into eukaryotic cell lines [44]. Our
system adds the advantage of avoiding marker expression
until recombination, making it versatile for synthetic
applications as well as genome-scale engineering.
Conclusions
We describe here the construction of new tools based on
two different site-specific recombination systems, the tyro-
sine recombinase HK, and the serine recombinase ΦC31.
Recombination for each system is reported based on the
reconstitution of the bla ampicillin resistance gene, provid-
ing resistance to β-lactam antibiotics as a selective agent.
Both HK-bla and ΦC31-bla are useful for selecting recom-
bination events in a genomic context due to a high rate of
recombination frequency, directionality based on the
recombination proteins supplied in trans, and the ability to
carry out in vivo genomic rearrangements. We have
previously used this tool in our lab to carry out large-
scale reorganization of the V. cholerae chromosomes to
study the importance of chromosome size in multi-
chromosomal bacteria [23], the relevance of genome pos-
ition and chromosome location for gene dosage and its
evolutionary importance [24], and the timing of V. cholerae
chromosome replication [25]. The importance of these
tools lie in their capacity to exist simultaneously in the cell
at two separate loci without expression of the marker gene
until expression of the recombination proteins is induced.
Methods
Bacterial strains and media
Bacterial strains used in this study are described in
Table 2. All strains were grown in lysogeny broth
(LB) medium at 30 °C, 37 °C, or 42 °C depending on plas-
mid temperature-sensitivity. Antibiotic and nutritional
supplement concentrations were as follows: ampicillin (Ap):
Table 2 Bacterial strains used in this study
E. coli
Name Genotype Reference/Source
β2163 (F−) RP4–2-Tc::Mu ΔdapA::(erm-pir) [KmR EmR] [29]
π1 DH5αΔthyA::(erm-pir116) [EmR] [29]
MFDpir MG1655 RP4–2-TC::[Mu1::aac(3)IV-ΔaphA-Δnic35-ΔMu2::zeo] ΔdapA::(erm-pir)ΔrecA[ApraR ZeoRErmR] [47]
PGB-8557 DH5α strain containing plasmids pHKΔ-Amp and pHK-Int [TcR SpR] this study
PGB-E274 DH5α strain containing plasmids pΦC31-attP and pΦC31-Int [TcR SpR] this study
One Shot ®
Top10
F- mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 Δ lacX74 recA1 araD139 Δ(araleu)7697 galU galK rpsL (StrR) endA1 nupG ThermoFisher
Scientific
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100 μg/ml, carbenicillin (Carb): 100 μg/ml, kanamycin (Km):
25 μg/ml, chloramphenicol, (Cm): 25 μg/ml, tetracyclin (Tc):
15 μg/ml, spectinomycin (Sp): 100 μg/ml, erythromycin
(Em): 20 μg/ml, with nutritional supplements diaminopime-
lic acid (DAP): 300 μM, and thymine (dT): 300 μM.
Cloning
Basic cloning steps were performed using the following
tools and appropriate protocols: for DNA purification, a
QIAquick PCR purification kit (QIAGEN) was used.
Plasmid minipreps were performed using the GeneJET
Plasmid Miniprep kit (Life Technologies). All PCR reac-
tions for plasmid construction were performed using the
Phusion High-Fidelity PCR Master Mix (Life Technolo-
gies), and all diagnostic PCR reactions were performed
using DreamTaq DNA Polymerase (Life Technologies).
Oligonucleotides were synthesized by Sigma-Aldrich and
Eurofins Genomics. Oligonucleotides were phosphory-
lated by T4 polynucleotide kinase (NEB). DNA was
sequenced by GATC Biotech and Eurofins Genomics.
Construction of plasmids
Insertion of attB sequences into pSW23T was performed
by annealing phosphorylated oligos containing the respect-
ive att sequence with overhangs overlapping with BamHI
and EcoRI restriction sites, followed by cloning of these
sequences into the pSW23T fragment. Insertion of attP
sequences into pHK11-Amp was similarly performed. The
various attB ORFs for both HK and ΦC31 were inserted
into the β-lactamase (bla) by overlapping PCR, in which
the 5′ region of bla was amplified from pMP58 using oligos
MV26 and the appropriate reverse attB oligo, and the 3′
bla region amplified using a forward attB oligo and JB13.
These products were gel purified and co-amplified using
oligos MV26 – JB13 to form a DNA fragment containing
bla with the inserted attB. This product was digested with
EagI and EcoRI and cloned into pSW23T and transformed
into MFDpir. The pMP58 bla gene comes from pUC19.
To make plasmid pPhiC31-Int, we first deleted the
XbaI site in pZJ7 (a kind gift of Jia Zhao and Sean
Colloms) by digestion with SpeI-XbaI followed by
religation to make plasmid pZJ7ΔXbaI. The ΦC31
Table 3 Plasmids used in this study
Name Description Reference/Source
pSW23T pSW23::oriTRP4; [CmR]; oriVR6K [29]
pSU38Δ orip15A [KmR] [48]
pHK-Int pGB2ts::cI857-λ-PR-HKInt, [SpR] [30]
pHK11-Amp pLDR11::attP_HK, [ApR,TcR] [30]
pSC101 pSC101ts, repA [TcR] [49]
pUC19 oriColE1, lacZα [ApR] [50]
pBAD43 oripSC101, PBAD::MCS,[SpR] [51]
pHK11Δamp pHK11-Amp::attP_HK,ΔAmp, [TcR] this study
pMP96 pSC101ts::cI857-λ-PR-(HKXis-HKInt λXis-λInt), [SpR] [23]
pMP58 pSC101ts::oriTRP4;repA, [CmR,ApR] this study
pMDG1 pMP58;bla::attB_HK,[ApR,CmR] this study
pMDG2 pSW23T::bla::attB_HK from pMDG1 this study
pMDG3 α/pSU38::attR_HK, [ApR] this study
pMDG4 pSW23T::attL_HK, [CmR] this study
pMJM1 pSW23T::attB_HKwt, [CmR] this study
pMJM2 pSW23T::attL_HKmut, [CmR] this study
pMJM3 pSW23T::attL_HK40, [CmR] this study
pMJM4 pSW23T::attL_HK30, [CmR] this study
pJB6 pSU38Δ::attR_HK-attL_λ, [ApR] this study
pJB7 pSW23T::attR_HK-attL_λ, [CmR] this study
pJB8 pBAD43::HKXis-HKInt λXis-λInt, [SpR] this study
pZJ7 pBAD33::ΦC31Int, [CmR] J. Zhao and S. Colloms
pZJ7ΔXbaI pZJ7 with SpeI – XbaI fragment deleted this study
pPhiC31-Int pGB2ts::cI857-λ-PR-ΦC31Int, [SpR] this study
pPhiC31-attP pHK11Δamp::attP_ΦC31, [TcR] this study
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integrase gene was amplified using oligos PhiC31 IntF
and PhiC31 IntR. The pHK-Int backbone was amplified
using oligos JB485 and JB486. These oligos produce DNA
fragments with overlapping ends, which were then joined
by Gibson assembly [45]. Plasmids used in this study are
listed in Table 3 and oligonucleotides in Table 4.
Recombination assay
Recombination frequencies were tested by performing a
conjugation assay in which the plasmid pSW23T
containing the oriTRP4 transfer region and oriVR6K π-
controlled replication origin were transferred from the
π+/DAP- donor strain MFDpir to a recipient strain
Table 4 Oligonucleotides used in this study
Oligonucleotide Sequence 5′ – 3′
PhiC31 Int F ATGTACTAATCTAGAGAAGAGGATCAGAAATGGACACGTACGCGGGTGC
PhiC31 Int R CAAGCTTGCATGCCTGCAGG
JB13 AGCGGGTGTTCCTTCTTCACTG
JB485 TCTTCTCTAGATTAGTACATGCAACCA
JB486 CGACTAGAGTCGACCTGCAGCCAAGCTTAGTAAAGCCCTC
MV26 ACGGCTGACATGGGAATTGC
MV143 CCTCTTACGTGCCGATCAACGTCTC
MV145 GCTGGTGATTCCGCTTTGCGACTCAACCTTTTTCACCTAAAGTGCACCGACCGTGA
MV146 ACATCAGCGATCACCTGGCAGAC
attBHKwtERI AATTCCGCTTTGCGACTCAACCTTTTTCACCTAAAGTGCACCGACCGTGAATG
attBHKwtREV GATCCATTCACGGTCGGTGCACTTTAGGTGAAAAAGGTTGAGTCGCAAAGCGG
attBHKmutERI AATTCCGCTTTGCGACACAACCTTTTTCACCTAAAGTGCACCGACCGTGAATG
attBHKmutREV GATCCATTCACGGTCGGTGCACTTTAGGTGAAAAAGGTTGTGTCGCAAAGCGG
40wtERI AATTCTGCGACTCAACCTTTTTCACCTAAAGTGCACCG
40wtREV GATCCCGGTGCACTTTAGGTGAAAAAGGTTGAGTCGCAG
40attBHKmutERI AATTCTGCGACACAACCTTTTTCACCTAAAGTGCACCG
40attBHKmutREV GATCCCGGTGCACTTTAGGTGAAAAAGGTTGTGTCGCAG
30wtERI AATTCTCAACCTTTTTCACCTAAAGTG
30wtREV GATCCACTTTAGGTGAAAAAGGTTGAG
30attBHKmutERI AATTCACAACCTTTTTCACCTAAAGTG
30attBHKmutREV GATCCACTTTAGGTGAAAAAGGTTGTG
30attBHKamp2ORF1min TTTGCTCACAACCTTTTTCACCTAAAGTGGCACCCAGAAACGCTGGTGAAAGTAAAAGATGCTGAAGATCAGTT
30attBHKamp1ORF1min CTTTCACCAGCGTTTCTGGGTGCCACTTTAGGTGAAAAAGGTTGTGAGCAAAAACAGGAAGGCAAAATGCCGC
30attBHKamp2ORF2min TTTGCTACACAACCTTTTTCACCTAAAGTGCACCCAGAAACGCTGGTGAAAGTAAAAGATGCTGAAGATCAGTT
30attBHKamp1ORF2min CTTTCACCAGCGTTTCTGGGTGCACTTTAGGTGAAAAAGGTTGTGTAGCAAAAACAGGAAGGCAAAATGCCGC
30attBHKamp2ORF3min TTTGCTGCCACTTTAGGTGAAAAAGGTTGTCACCCAGAAACGCTGGTGAAAGTAAAAGATGCTGAAGATCAGTT
30attBHKamp1ORF3min CTTTCACCAGCGTTTCTGGGTGACAACCTTTTTCACCTAAAGTGGCAGCAAAAACAGGAAGGCAAAATGCCGC
phiC31 ORF1 F TTTGCTTGCGGGTGCCAGGGCGTGCCCTTGGGCTCCCCGGGCGCGTACTCCCACCCAGAAACGCTGGTGAAAG
phiC31 ORF2 F TTTGCTGCGGGTGCCAGGGCGTGCCCTTGGGCTCCCCGGGCGCGTACTCCCCACCCAGAAACGCTGGTGAAAG
phiC31 ORF3 F TTTGCTCGGGTGCCAGGGCGTGCCCTTGGGCTCCCCGGGCGCGTACTCCCCCACCCAGAAACGCTGGTGAAAG
phiC31 ORF4 F TTTGCTGGAGTACGCGCCCGGGGAGCCCAAGGGCACGCCCTGGCACCCGCACACCCAGAAACGCTGGTGAAAG
phiC31 ORF5 F TTTGCTGGGAGTACGCGCCCGGGGAGCCCAAGGGCACGCCCTGGCACCCGCCACCCAGAAACGCTGGTGAAAG
phiC31 ORF6 F TTTGCTGGGGAGTACGCGCCCGGGGAGCCCAAGGGCACGCCCTGGCACCCGCACCCAGAAACGCTGGTGAAAG
phiC31 ORF1 R CTTTCACCAGCGTTTCTGGGTGGGAGTACGCGCCCGGGGAGCCCAAGGGCACGCCCTGGCACCCGCAAGCAAAAACAGGAAGGCAAAATG
phiC31 ORF2 R CTTTCACCAGCGTTTCTGGGTGGGGAGTACGCGCCCGGGGAGCCCAAGGGCACGCCCTGGCACCCGCAGCAAAAACAGGAAGGCAAAATG
phiC31 ORF3 R CTTTCACCAGCGTTTCTGGGTGGGGGAGTACGCGCCCGGGGAGCCCAAGGGCACGCCCTGGCACCCGAGCAAAAACAGGAAGGCAAAATG
phiC31 ORF4 R CTTTCACCAGCGTTTCTGGGTGTGCGGGTGCCAGGGCGTGCCCTTGGGCTCCCCGGGCGCGTACTCCAGCAAAAACAGGAAGGCAAAATG
phiC31 ORF5 R CTTTCACCAGCGTTTCTGGGTGGCGGGTGCCAGGGCGTGCCCTTGGGCTCCCCGGGCGCGTACTCCCAGCAAAAACAGGAAGGCAAAATG
phiC31 ORF6 R CTTTCACCAGCGTTTCTGGGTGCGGGTGCCAGGGCGTGCCCTTGGGCTCCCCGGGCGCGTACTCCCCAGCAAAAACAGGAAGGCAAAATG
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containing an attP plasmid and a helper plasmid express-
ing the appropriate integrase gene under control of the
temperature-sensitive CI857 promoter. Prior to conjuga-
tion, strains were diluted 1/100 from an overnight starter
culture and grown to OD600 = 0.3. Conjugations were per-
formed by two techniques: for the attB HKWT/MUT strains,
0.5 ml of donor was mixed with 4.5 ml of recipient and
applied to a 0.45 μm filter (Millipore) by vacuum-filtration
through a glass column. The attB ORF insertions into bla
were performed by mixing 0.2 ml of donor with 1.8 ml of
recipient, and following centrifugation at 6000 RPM for
5 min, ~1.8 ml of supernatant was removed, the pellet
resuspended in the remaining liquid media, and similarly
placed onto a 0.45 μm filter. For both techniques, the
filters were then incubated on an LB-DAP plate for
approx. 16 h prior to resuspension and plating. Recombi-
nants were recovered by selecting for Cm resistance in
DAP-free media, and recombination frequencies were
measured as the ratio of recovered recombinants over
donor CFUs. Each att site was tested three times.
Minimum inhibitory concentration (MIC)
The MICs of E. coli strains containing plasmids with
either attB inserted into bla, or bla fragments associated
with attL and attR were performed by plating and aspir-
ating 2 ml of a 1/100 dilution of an overnight culture
onto an LB/DAP agar petri dish. An Etest (bioMérieux)
ampicillin antibiotic strip was placed onto the plate and
incubated overnight at 37 °C, and the level of antibiotic
resistance was scored the following day.
Data analysis
Recombination frequencies were analyzed for statistical
significance using MATLAB software (The MathWorks,
Inc., Natick, MA). 1 and 2-way analysis of variance
(ANOVA) tests were performed using the anova1 and
anova2 functions. Tukey-Kramer post-hoc tests were
performed using the multcompare function.
DNA folding and protein structure analysis
Secondary DNA structures were analyzed using the mfold
software [46]. Protein residue charges were calculated by
counting negatively charged residues Asp and Glu as −1,
and positively charged His, Lys, and Arg as +1.
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